Valuation: Ono Pharmaceutical Co., Ltd.

Market Cap 1,106B 6.98B 6.26B 5.73B 5.23B 9.85B 657B 10.16B 69.01B 27.52B 350B 26.22B 25.65B P/E 2027 *
14.7x
P/E 2028 * 17.2x
Enterprise Value 904B 5.71B 5.12B 4.68B 4.27B 8.05B 537B 8.3B 56.41B 22.49B 286B 21.43B 20.97B EV / Sales 2027 *
1.96x
EV / Sales 2028 * 1.91x
Free-Float
82.24%
Yield 2027 *
3.4%
Yield 2028 * 3.4%
1 day-5.48%
1 week+4.28%
Current month+4.28%
1 month+3.45%
3 months+0.62%
6 months+1.60%
Current year+8.29%
1 week 2,278
Extreme 2278
2,527.5
1 month 2,111.5
Extreme 2111.5
2,565.5
Current year 2,111.5
Extreme 2111.5
2,674.5
1 year 1,908.5
Extreme 1908.5
2,674.5
3 years 1,474
Extreme 1474
2,849
5 years 1,474
Extreme 1474
3,990
10 years 1,474
Extreme 1474
3,990
Manager TitleAgeSince
Chief Executive Officer 68 2024-03-31
Director of Finance/CFO - 2026-03-31
President 57 2024-03-31
Director TitleAgeSince
Chairman 68 2024-03-31
Director/Board Member 57 2020-05-31
Director/Board Member 77 2018-06-25
Change 5-day change 1-year change 3-year change Capi.($)
-5.48%+4.28%+21.20%-9.55% 6.98B
-0.79%-4.48%+44.44%+127.49% 1,206B
+1.43%+1.11%+47.73%+82.08% 665B
+1.07%-1.21%+32.99%+106.31% 515B
-0.36%-3.25%+47.17%+64.58% 381B
-0.14%-1.87%+71.05%+40.63% 362B
-0.78%-0.52%+30.57%+57.98% 307B
-0.80%-0.21%+8.54%+35.56% 289B
+0.03%-1.20%+45.89%+68.76% 249B
-0.41%-2.22%+35.24%+105.68% 207B
Average -0.62%-0.96%+38.48%+67.95% 418.67B
Weighted average by Cap. -0.05%-1.95%+42.20%+88.22%

Financials

2027 *2028 *
Net sales 461B 2.91B 2.61B 2.39B 2.18B 4.11B 274B 4.23B 28.77B 11.47B 146B 10.93B 10.7B 448B 2.83B 2.54B 2.32B 2.12B 3.99B 266B 4.12B 27.97B 11.15B 142B 10.62B 10.4B
Net income 75.38B 476M 427M 390M 356M 671M 44.75B 692M 4.7B 1.88B 23.88B 1.79B 1.75B 64.18B 405M 364M 332M 303M 571M 38.1B 589M 4B 1.6B 20.33B 1.52B 1.49B
Net Debt -202B -1.28B -1.14B -1.05B -954M -1.8B -120B -1.85B -12.6B -5.02B -63.97B -4.79B -4.68B -251B -1.59B -1.42B -1.3B -1.19B -2.24B -149B -2.31B -15.68B -6.25B -79.58B -5.96B -5.83B
Projected Income Statement - Annual - Ono Pharmaceutical Co., Ltd.
Logo Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the pharmaceutical business. The Company is engaged in the manufacture and sale of prescription and over-the-counter drugs. The Company has been particularly focused on research and development of prescription drugs, positioning them as its core business. The Company’s products include injectables, oral medications, and patches.
Employees
4,206
Date Price Change Volume
26-11-06 JP¥2,352.50 -5.48% 1,838,600
26-11-05 JP¥2,489.00 +4.62% 2,448,600
26-11-04 JP¥2,379.00 +2.94% 2,622,200
26-11-02 JP¥2,311.00 +2.44% 2,154,700
26-10-30 JP¥2,256.00 +1.42% 3,543,500
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Ono Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
2,352.50JPY
Average target price
2,512.50JPY
Spread / Average Target
+6.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Ono Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 4528 Stock